
Amsterdam Finds Treatment for Fatal Child Brain Disease
A blood pressure drug is giving hope to children with a rare, deadly brain disease that previously had no cure. Young patients treated with guanabenz lived longer and maintained mobility while their brain deterioration slowed or stopped.
Researchers at Amsterdam's Emma Children's Hospital just gave families facing a heartbreaking diagnosis something they've never had before: hope.
For the first time, doctors have found a treatment for vanishing white matter disease, a rare genetic brain condition that mostly strikes children between ages 1 and 6. Until now, families could only watch as the disease took their children's lives, with no way to fight back.
The breakthrough came from an unexpected place. Guanabenz, a drug normally used to treat high blood pressure, turned out to slow or even stop the brain damage caused by VWM.
In a four-year trial, 33 children from around the world received the drug while 66 others served as a comparison group. The results published in The Lancet Neurology showed striking differences.
Children who took guanabenz stayed mobile longer and needed wheelchairs less often than those who didn't receive treatment. Even more importantly, all the children in the treatment group survived, while five children in the comparison group died during the study period.

"We saw that the disappearance of the white matter in the brain slowed down or even stopped," said lead researcher Marjo van der Knaap. The white matter in our brains helps different parts communicate with each other, and when it vanishes, children lose the ability to move, think, and eventually survive.
VWM affects about 1 in 100,000 people in the Netherlands. While that might sound rare, it represents real families desperate for any chance to save their children.
Why This Inspires
This discovery shows how sometimes the answers we're searching for already exist right in front of us. A drug that's been around for decades, sitting on pharmacy shelves treating blood pressure, turned out to hold the key to saving children's lives.
The researchers aren't stopping here. They're planning long-term studies to confirm these results and working to get approval from the European Medicines Agency so doctors can officially prescribe guanabenz for VWM.
For families who once had no options, there's now a fighting chance.
Based on reporting by Google News - Researchers Find
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


